30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Adaptive Biotechnologies Corp (ADPT)

Track

Over the last 90 days, Adaptive Biotechnologies Corp. has seen significant insider selling, with a net value of -$406,196. All reported transactions were sales, totaling over $16.5 million. Notably, officers and executives have been the primary sellers, with multiple large proposed and planned sales occurring in April and June.
Stock chart
Ticker: ADPT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ROBINS HARLAN S
Chief Scientific Officer
1 sale — total 100,000 USD
Planned sale 16 Jun 2026
Value US$2,195,021.95 | Price 437.06 | Shares 31,049
Proposed sale 16 Jun 2026
Value US$1,439,677.38 | Price 143.14 | Shares 44,975
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 17.37 | Shares 1,000
Proposed sale 15 Jun 2026
Value US$100,000.00 | Price 17.46 | Shares 1,000
Planned sale 11 Jun 2026
Value US$100,000.00 | Price 19.00 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 17.07 | Shares 1,000
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 18.00 | Shares 1,000
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 17.49 | Shares 1,000
Proposed sale 4 Jun 2026
Value US$100,000.00 | Price 15.99 | Shares 1,000
Proposed sale 4 Jun 2026
Value US$100,000.00 | Price 15.99 | Shares 1,000
Sale 18 May 2026
Value US$40,619.60 | Price 13.04 | Shares 3,115
Proposed sale 18 May 2026
Value US$40,542.80 | Price 12.83 | Shares 3,160
Planned sale 27 Apr 2026
Value US$270,896.51 | Price 14.23 | Shares 19,037
Planned sale 24 Apr 2026
Value US$267,221.20 | Price 14.02 | Shares 19,060
Planned sale 23 Apr 2026
Value US$261,884.40 | Price 13.74 | Shares 19,060
Planned sale 22 Apr 2026
Value US$269,317.80 | Price 14.13 | Shares 19,060
Planned sale 21 Apr 2026
Value US$453,595.06 | Price 14.66 | Shares 30,941
Planned sale 20 Apr 2026
Value US$277,323.00 | Price 14.55 | Shares 19,060
Planned sale 17 Apr 2026
Value US$277,704.20 | Price 14.57 | Shares 19,060
Planned sale 16 Apr 2026
Value US$270,270.80 | Price 14.18 | Shares 19,060
Planned sale 15 Apr 2026
Value US$278,466.60 | Price 14.61 | Shares 19,060
Planned sale 14 Apr 2026
Value US$277,513.60 | Price 14.56 | Shares 19,060
Planned sale 13 Apr 2026
Value US$46,999.04 | Price 14.08 | Shares 3,338
Planned sale 13 Apr 2026
Value US$203,599.90 | Price 12.95 | Shares 15,722
Planned sale 10 Apr 2026
Value US$5,392.00 | Price 13.48 | Shares 400
Planned sale 10 Apr 2026
Value US$237,915.00 | Price 12.75 | Shares 18,660
Planned sale 9 Apr 2026
Value US$30,324.00 | Price 14.44 | Shares 2,100
Planned sale 9 Apr 2026
Value US$233,878.40 | Price 13.79 | Shares 16,960
Planned sale 8 Apr 2026
Value US$340,039.48 | Price 15.07 | Shares 22,564
Planned sale 8 Apr 2026
Value US$148,500.00 | Price 14.85 | Shares 10,000
Planned sale 8 Apr 2026
Value US$566,024.97 | Price 15.19 | Shares 37,263
Planned sale 8 Apr 2026
Value US$1,548.00 | Price 15.48 | Shares 100
Planned sale 8 Apr 2026
Value US$457,372.03 | Price 14.83 | Shares 30,841
Proposed sale 8 Apr 2026
Value US$552,982.92 | Price 14.84 | Shares 37,263
Proposed sale 8 Apr 2026
Value US$148,400.00 | Price 14.84 | Shares 10,000
Proposed sale 8 Apr 2026
Value US$309,352.44 | Price 13.71 | Shares 22,564
Planned sale 7 Apr 2026
Value US$258,453.60 | Price 13.56 | Shares 19,060
Planned sale 6 Apr 2026
Value US$1,200,814.12 | Price 14.41 | Shares 83,332
Planned sale 6 Apr 2026
Value US$273,129.80 | Price 14.33 | Shares 19,060
Proposed sale 6 Apr 2026
Value US$1,173,314.56 | Price 14.08 | Shares 83,332
Planned sale 2 Apr 2026
Value US$278,276.00 | Price 14.60 | Shares 19,060
Planned sale 2 Apr 2026
Value US$278,276.00 | Price 14.60 | Shares 19,060
Planned sale 1 Apr 2026
Value US$275,417.00 | Price 14.45 | Shares 19,060
Planned sale 1 Apr 2026
Value US$275,417.00 | Price 14.45 | Shares 19,060
Planned sale 31 Mar 2026
Value US$256,357.00 | Price 13.45 | Shares 19,060
Planned sale 30 Mar 2026
Value US$240,727.80 | Price 12.63 | Shares 19,060
Planned sale 27 Mar 2026
Value US$220,020.56 | Price 13.48 | Shares 16,322
Planned sale 27 Mar 2026
Value US$34,197.62 | Price 12.49 | Shares 2,738
Planned sale 26 Mar 2026
Value US$269,127.20 | Price 14.12 | Shares 19,060
Planned sale 25 Mar 2026
Value US$271,986.20 | Price 14.27 | Shares 19,060
Planned sale 24 Mar 2026
Value US$261,122.00 | Price 13.70 | Shares 19,060
Planned sale 23 Mar 2026
Value US$263,599.80 | Price 13.83 | Shares 19,060
Planned sale 20 Mar 2026
Value US$254,832.20 | Price 13.37 | Shares 19,060
Planned sale 19 Mar 2026
Value US$251,210.80 | Price 13.18 | Shares 19,060
Planned sale 18 Mar 2026
Value US$251,210.80 | Price 13.18 | Shares 19,060
Planned sale 17 Mar 2026
Value US$255,404.00 | Price 13.40 | Shares 19,060
Planned sale 16 Mar 2026
Value US$255,594.60 | Price 13.41 | Shares 19,060
Planned sale 13 Mar 2026
Value US$247,017.60 | Price 12.96 | Shares 19,060
Planned sale 12 Mar 2026
Value US$72,522.00 | Price 13.43 | Shares 5,400
Planned sale 12 Mar 2026
Value US$172,525.80 | Price 12.63 | Shares 13,660
Proposed sale 11 Mar 2026
Value US$600,227.76 | Price 14.52 | Shares 41,338
Sale 11 Mar 2026
Value US$544,421.46 | Price 13.17 | Shares 41,338
Proposed sale 11 Mar 2026
Value US$916,255.56 | Price 14.52 | Shares 63,103
Sale 11 Mar 2026
Value US$831,066.51 | Price 13.17 | Shares 63,103
Proposed sale 11 Mar 2026
Value US$271,117.44 | Price 14.52 | Shares 18,672
Sale 11 Mar 2026
Value US$245,910.24 | Price 13.17 | Shares 18,672
Proposed sale 11 Mar 2026
Value US$1,779,033.96 | Price 14.52 | Shares 122,523
Planned sale 11 Mar 2026
Value US$268,364.80 | Price 14.08 | Shares 19,060
Sale 11 Mar 2026
Value US$1,613,627.91 | Price 13.17 | Shares 122,523
Proposed sale 11 Mar 2026
Value US$6,828,262.32 | Price 14.52 | Shares 470,266
Sale 11 Mar 2026
Value US$4,340,832.00 | Price 13.17 | Shares 329,600
Sale 11 Mar 2026
Value US$1,852,571.22 | Price 13.17 | Shares 140,666
Proposed sale 11 Mar 2026
Value US$6,826,824.84 | Price 14.52 | Shares 470,167
Sale 11 Mar 2026
Value US$214,130.54 | Price 13.91 | Shares 15,394
Planned sale 11 Mar 2026
Value US$430,749.44 | Price 14.08 | Shares 30,593
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
31,049 +20.5%
437.06
US$2,195,022 		31,049 +20.5% 437.06 US$2,195,022
2026-06-16 2026-06-16 PrS Proposed sale
2.1
Harlan Robins

Officer

Officer
44,975
143.14
US$1,439,677 		44,975 143.14 US$1,439,677
2026-06-17 2026-06-15 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
6,304 +27.2%
213.84
US$1,517,929 		6,304 +27.2% 213.84 US$1,517,929
2026-06-15 2026-06-15 PrS Proposed sale
2.1
Harlan Robins

Officer

Officer
1,000
17.46
US$100,000 		1,000 17.46 US$100,000
2026-06-15 2026-06-11 PlS Planned sale
2.0
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
1,000 -1.2%
19.00
US$100,000 		1,000 -1.2% 19.00 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
2.0
SUSAN BOBULSKY

Officer

Officer
1,000
17.07
US$100,000 		1,000 17.07 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
2.0
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
1,000 -2.6%
18.00
US$100,000 		1,000 -2.6% 18.00 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
1,000 -13.7%
17.49
US$100,000 		1,000 -13.7% 17.49 US$100,000
2026-06-04 2026-06-04 PrS Proposed sale
2.0
SUSAN BOBULSKY

Officer

Officer
1,000
15.99
US$100,000 		1,000 15.99 US$100,000
2026-06-04 2026-06-04 PrS Proposed sale
2.6
FRANCIS LO

Officer

Officer
1,000
15.99
US$100,000 		1,000 15.99 US$100,000
2026-05-20 2026-05-18 S Sale
2.7
PISKEL KYLE

Chief Financial Officer

Officer
3,115 -1.2%
13.04
US$40,620 		3,115 -1.2% 13.04 US$40,620
2026-05-15 2026-05-18 PrS Proposed sale
2.7
PISKEL KYLE

Officer

Officer
3,160
12.83
US$40,543 		3,160 12.83 US$40,543
2026-04-29 2026-04-27 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,037 -4.8%
14.23
US$270,897 		19,037 -4.8% 14.23 US$270,897
2026-04-24 2026-04-24 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.8%
14.02
US$267,221 		19,060 -4.8% 14.02 US$267,221
2026-04-24 2026-04-23 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.7%
13.74
US$261,884 		19,060 -4.7% 13.74 US$261,884
2026-04-24 2026-04-22 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.7%
14.13
US$269,318 		19,060 -4.7% 14.13 US$269,318
2026-04-21 2026-04-21 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
30,941 -7.3%
14.66
US$453,595 		30,941 -7.3% 14.66 US$453,595
2026-04-21 2026-04-20 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.6%
14.55
US$277,323 		19,060 -4.6% 14.55 US$277,323
2026-04-21 2026-04-17 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.5%
14.57
US$277,704 		19,060 -4.5% 14.57 US$277,704
2026-04-16 2026-04-16 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.5%
14.18
US$270,271 		19,060 -4.5% 14.18 US$270,271
2026-04-16 2026-04-15 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.4%
14.61
US$278,467 		19,060 -4.4% 14.61 US$278,467
2026-04-16 2026-04-14 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.4%
14.56
US$277,514 		19,060 -4.4% 14.56 US$277,514
2026-04-13 2026-04-13 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
3,338 -0.8%
14.08
US$46,999 		3,338 -0.8% 14.08 US$46,999
2026-04-13 2026-04-13 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
15,722 -3.6%
12.95
US$203,600 		15,722 -3.6% 12.95 US$203,600
2026-04-13 2026-04-10 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
400 -0.1%
13.48
US$5,392 		400 -0.1% 13.48 US$5,392
2026-04-13 2026-04-10 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
18,660 -4.2%
12.75
US$237,915 		18,660 -4.2% 12.75 US$237,915
2026-04-13 2026-04-09 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
2,100 -0.5%
14.44
US$30,324 		2,100 -0.5% 14.44 US$30,324
2026-04-13 2026-04-09 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
16,960 -3.8%
13.79
US$233,878 		16,960 -3.8% 13.79 US$233,878
2026-04-10 2026-04-08 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
22,564 -7.7%
15.07
US$340,039 		22,564 -7.7% 15.07 US$340,039
2026-04-10 2026-04-08 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
10,000 -0.7%
14.85
US$148,500 		10,000 -0.7% 14.85 US$148,500
2026-04-08 2026-04-08 PlS Planned sale
2.3
ROBINS CHAD M

CEO and Chairman

Executive Director
37,263 -1.7%
15.19
US$566,025 		37,263 -1.7% 15.19 US$566,025
2026-04-08 2026-04-08 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
100 -0.0%
15.48
US$1,548 		100 -0.0% 15.48 US$1,548
2026-04-08 2026-04-08 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
30,841 -6.6%
14.83
US$457,372 		30,841 -6.6% 14.83 US$457,372
2026-04-08 2026-04-08 PrS Proposed sale
2.3
Chad Robins

Officer

Officer
37,263
14.84
US$552,983 		37,263 14.84 US$552,983
2026-04-08 2026-04-08 PrS Proposed sale
2.1
Harlan Robins

Officer

Officer
10,000
14.84
US$148,400 		10,000 14.84 US$148,400
2026-04-08 2026-04-08 PrS Proposed sale
2.6
FRANCIS LO

Officer

Officer
22,564
13.71
US$309,352 		22,564 13.71 US$309,352
2026-04-08 2026-04-07 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.2%
13.56
US$258,454 		19,060 -4.2% 13.56 US$258,454
2026-04-08 2026-04-06 PlS Planned sale
2.3
ROBINS CHAD M

CEO and Chairman

Executive Director
83,332 -3.6%
14.41
US$1,200,814 		83,332 -3.6% 14.41 US$1,200,814
2026-04-08 2026-04-06 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.1%
14.33
US$273,130 		19,060 -4.1% 14.33 US$273,130
2026-04-06 2026-04-06 PrS Proposed sale
2.3
Chad Robins

Officer

Officer
83,332
14.08
US$1,173,315 		83,332 14.08 US$1,173,315
2026-04-02 2026-04-02 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.1%
14.60
US$278,276 		19,060 -4.1% 14.60 US$278,276
2026-04-02 2026-04-02 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.1%
14.60
US$278,276 		19,060 -4.1% 14.60 US$278,276
2026-04-02 2026-04-01 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.1%
14.45
US$275,417 		19,060 -4.1% 14.45 US$275,417
2026-04-02 2026-04-01 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.1%
14.45
US$275,417 		19,060 -4.1% 14.45 US$275,417
2026-03-31 2026-03-31 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.0%
13.45
US$256,357 		19,060 -4.0% 13.45 US$256,357
2026-03-31 2026-03-30 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.0%
12.63
US$240,728 		19,060 -4.0% 12.63 US$240,728
2026-03-31 2026-03-27 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
16,322 -3.4%
13.48
US$220,021 		16,322 -3.4% 13.48 US$220,021
2026-03-31 2026-03-27 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
2,738 -0.6%
12.49
US$34,198 		2,738 -0.6% 12.49 US$34,198
2026-03-26 2026-03-26 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.9%
14.12
US$269,127 		19,060 -3.9% 14.12 US$269,127
2026-03-26 2026-03-25 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.9%
14.27
US$271,986 		19,060 -3.9% 14.27 US$271,986
2026-03-26 2026-03-24 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.8%
13.70
US$261,122 		19,060 -3.8% 13.70 US$261,122
2026-03-23 2026-03-23 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.8%
13.83
US$263,600 		19,060 -3.8% 13.83 US$263,600
2026-03-23 2026-03-20 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.8%
13.37
US$254,832 		19,060 -3.8% 13.37 US$254,832
2026-03-23 2026-03-19 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.7%
13.18
US$251,211 		19,060 -3.7% 13.18 US$251,211
2026-03-18 2026-03-18 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.7%
13.18
US$251,211 		19,060 -3.7% 13.18 US$251,211
2026-03-18 2026-03-17 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.7%
13.40
US$255,404 		19,060 -3.7% 13.40 US$255,404
2026-03-18 2026-03-16 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.6%
13.41
US$255,595 		19,060 -3.6% 13.41 US$255,595
2026-03-13 2026-03-13 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.6%
12.96
US$247,018 		19,060 -3.6% 12.96 US$247,018
2026-03-13 2026-03-12 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
5,400 -1.0%
13.43
US$72,522 		5,400 -1.0% 13.43 US$72,522
2026-03-13 2026-03-12 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
13,660 -2.6%
12.63
US$172,526 		13,660 -2.6% 12.63 US$172,526
2026-03-16 2026-03-11 PrS Proposed sale
2.0
BOBULSKY SUSAN

Officer

Officer
41,338
14.52
US$600,228 		41,338 14.52 US$600,228
2026-03-16 2026-03-11 PrS Proposed sale
2.5
BENZENO SHARON

Officer

Officer
63,103
14.52
US$916,256 		63,103 14.52 US$916,256
2026-03-16 2026-03-11 PrS Proposed sale
2.7
PISKEL KYLE

Officer

Officer
18,672
14.52
US$271,117 		18,672 14.52 US$271,117
2026-03-16 2026-03-11 PrS Proposed sale
3.1
RUBINSTEIN JULIE

Officer

Officer
122,523
14.52
US$1,779,034 		122,523 14.52 US$1,779,034
2026-03-16 2026-03-11 PrS Proposed sale
2.1
ROBINS HARLAN S

Officer

Officer
470,266
14.52
US$6,828,262 		470,266 14.52 US$6,828,262
2026-03-16 2026-03-11 PrS Proposed sale
2.3
ROBINS CHAD M

Officer; Director

Executive Director
470,167
14.52
US$6,826,825 		470,167 14.52 US$6,826,825
2026-03-13 2026-03-11 PlS Planned sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
19,060 -3.6%
14.08
US$268,365 		19,060 -3.6% 14.08 US$268,365
2026-03-13 2026-03-11 S Sale
3.1
RUBINSTEIN JULIE

President and COO

Officer
122,523 -19.0%
13.17
US$1,613,628 		122,523 -19.0% 13.17 US$1,613,628
2026-03-13 2026-03-11 S Sale
1.2
GRIFFIN MICHELLE RENEE
Non-Executive Director
15,394 -49.6%
13.91
US$214,131 		15,394 -49.6% 13.91 US$214,131
2026-03-13 2026-03-11 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
30,593 -9.5%
14.08
US$430,749 		30,593 -9.5% 14.08 US$430,749
2026-03-13 2026-03-11 S Sale
2.0
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
41,338 -8.8%
13.17
US$544,421 		41,338 -8.8% 13.17 US$544,421
2026-03-13 2026-03-11 S Sale
2.5
BENZENO SHARON

Chief Commercial Ofc Imm Med

Officer
63,103 -18.8%
13.17
US$831,067 		63,103 -18.8% 13.17 US$831,067
2026-03-13 2026-03-11 S Sale
2.7
PISKEL KYLE

Chief Financial Officer

Officer
18,672 -6.7%
13.17
US$245,910 		18,672 -6.7% 13.17 US$245,910
2026-03-13 2026-03-11 S Sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
329,600 -17.8%
13.17
US$4,340,832 		329,600 -17.8% 13.17 US$4,340,832
2026-03-13 2026-03-11 S Sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
140,666 -7.1%
13.17
US$1,852,571 		140,666 -7.1% 13.17 US$1,852,571
Explore more

More insider trading research around Adaptive Biotechnologies Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America